Switch to Dark

Pricing

Learn

IDXX - IDEXX Laboratories Inc

221

$579.85

$2.73 (0.473%)

At market close

$579.86

$0.01 (0.002%)

After Hours 3/19/26, 8:02 PM

Score

4.06/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Metric Margins Overview

Metrics

KPIs

View as %

IDEXX Laboratories Inc

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Operating Margin	11.34%	8.43%	30.79%	31.21%	29.14% 2025-03-31	31.6% 2025-12-31	31.6% 2025-12-31

Net Margin	10.96%	8.15%	24.11%	24.51%	22.76% 2025-03-31	24.65% 2025-09-30	24.62% 2025-12-31

Gross Margin	1.13%	0.85%	61.58%	61.63%	61.28% 2025-03-31	61.8% 2025-12-31	61.8% 2025-12-31

Free Cash Flow Margin	18.73%	13.81%	21.82%	21.93%	19.18% 2025-06-30	24.25% 2025-12-31	24.25% 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Margins
Gross Margin	61.80%	61.72%	61.54%	61.28%	42K%	117751	5475628	4724333	2679111	837513	614156	3632542	4195367	6819825	3889279	6134633	150121	4592750
SGA Margin	24.36%	24.57%	24.69%	26.38%	42K%	1838412	295645	112869	9582151	7855590	5698653	8879465	3766893	9252699	8322529	6462935	4331597	5412982
Operating Margin	31.60%	31.34%	31.09%	29.14%	42K%	5786083	208186	9425852	891136	8340751	5049525	6122761	3219047	5848969	9577318	7583001	4097490	6068433
EBITDA Margin	34.97%	34.70%	34.50%	32.55%	42K%	576952	6494752	7305765	4364193	838336	2003264	6870678	1760550	7663317	6534047	2072667	3294634	3720425
Net Margin	24.62%	24.65%	24.41%	22.76%	42K%	3119003	723084	5381700	5139312	1387868	8921413	5397575	9400662	8070215	8363449	1669823	9295491	4039180
Free Cash Flow Margin	24.25%	22.56%	19.18%	21.31%	42K%	4081114	1703710	6718680	210484	7597754	2789056	5741862	8110978	3667014	3285745	4766070	3757246	5619603
Operating Cash Flow Margin	27.46%	26.11%	22.43%	24.63%	42K%	7823359	7112162	7793111	8616978	8406904	6756662	4221503	2813997	318330	7307663	4247090	1757398	8254750
Valuation Metrics
Market Cap	54,021,816	51,114,200	43,133,492	34,032,344	42,069,000	4983583	2808777	73853	8485491	6610702	6163320	251579	9872828	1758517	7870806	9040953	3114019	6853497
Enterprise Value	54,689,583	51,885,856	44,072,704	34,808,602	42,069,000	6854711	6216451	8324179	2864994	5539185	7730680	4812453	1352247	5708268	4590001	6989449	6983287	6949348
Price to Sales	12.55	12.27	10.68	8.66	42,069	6890535	7584988	3900401	5142323	8069000	5725464	4462959	1783933	1295364	4369368	3783341	3608654	511269
Price to Gross	20.31	19.87	17.36	14.13	42,069	8359335	6482129	8898200	324082	1015244	5703527	533662	589657	3624338	7743776	5774864	4021657	1479633
Price to Operating Cash Flow	45.71	46.98	47.62	35.14	42,069	9168445	967084	1851393	6119086	3231477	3739427	1317342	3422032	3219440	2381736	5453134	462432	2670567
Price to Operating Income	39.72	39.13	34.36	29.7	42,069	3231983	8267255	7421869	2420909	8913641	3878237	3219590	4803895	6996100	5778831	6570644	1320241	393555
Price to Earnings	50.99	49.75	43.76	38.03	42,069	7005388	5120347	8758921	7123738	2394374	6299885	2477990	673500	1376407	1023306	3143919	7894229	232120
Price to Free Cash Flow	51.77	54.36	55.7	40.63	42,069	5105556	9146705	525531	5279731	219839	3026680	4925743	1832356	668930	4292065	4950454	4724003	5000470
Management
Return On Assets	31.62%	30.34%	29.59%	27.85%	42K%	2719742	9752475	349920	423847	7600422	4167685	3543095	2164522	2502087	795769	6286821	1849103	2823218
Return On Capital Employed	61.76%	61.18%	59.57%	55.16%	42K%	3668951	705988	7886711	1591768	4418320	3420327	1017681	8191267	109432	3279821	5834855	2590540	9904919
Return On Equity	65.99%	65.81%	67.56%	61.81%	42K%	3542801	1538113	4691916	5476095	7088043	4755059	3389427	3532091	1439460	6793307	3729497	4662470	7755176
Return On Invested Capital	48.18%	45.44%	42.25%	41.20%	42K%	6559720	9306144	3491194	7917032	1292373	266937	8812927	7995717	520058	4380843	9329935	181892	137656
Stock Based Compensation
SBC as a % of FCF	5.75%	6.19%	7.70%	7.22%	42K%	1082612	246601	1318742	6549792	1551582	2158281	9550503	7002514	405129	9198297	4950671	6337940	1543742
SBC as a % of OCF	5.08%	5.35%	6.59%	6.25%	42K%	6984980	3335036	7798394	6713289	4904424	1722606	7120825	84486	194675	6116839	1518376	1311614	1253097
SBC as a % of Revenue	1.39%	1.40%	1.48%	1.54%	42K%	3813998	6995779	2225250	6538394	274495	7091006	8321140	5752081	6692482	4200134	1662776	4090222	7951211
FCF Excl. SBC Yield	1.82%	1.73%	1.66%	2.28%	42K%	3156167	8289213	8827577	3510529	4301493	7155203	42233	7124414	8856275	5845920	5639314	7394379	5589206
Per Share
Free Cash Flow Per Share	12.97	11.65	9.56	10.23	42,069	6916669	904771	7489061	1049911	4275228	2027678	2422070	6659199	3077916	9214252	5675006	7313774	9536395
Operating Cash Flow Per Share	14.68	13.49	11.18	11.82	42,069	9655696	5570108	2167744	2067815	8587292	1623378	1877648	4486689	6978946	5399680	9898825	4797881	99059
Revenue Per Share	53.48	51.66	49.85	47.99	42,069	3909938	3691968	4656458	7115456	6916013	1560861	6407115	6214693	763872	6732689	1453264	6814325	2447096
Financial Health
Debt to EBITDA Ratio	0.56	0.68	0.79	0.73	42,069	2999817	1089982	7727785	8473643	2792435	6909083	7348659	9695897	2909332	8091258	5970942	7062112	3725754
Interest Coverage Ratio	35.01	35.17	36.72	37.01	42,069	6088496	7016712	6668406	8512574	5541725	2633875	8216498	7493111	4196974	6439351	4975009	8405171	6742421
Net Debt	667,767	771,656	939,212	776,258	42,069,000	255153	875621	4794684	5561051	8015264	7151947	452994	8160755	3387390	364378	258173	6978037	1562827
Total Debt	847,837	979,822	1,103,806	940,228	42,069,000	4046351	3053935	6769522	7649087	2795940	6746764	2634292	2566443	5998835	7770589	6224030	7251727	7220311